Community Healthcare Trust Inc logo

Community Healthcare Trust Inc(CHCT)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$14.71
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for CHCT

11/13/2026: CHCT (1-star) is currently NOT-A-BUY. Pass it for now.

Community Healthcare Trust Inc is a small-cap healthcare real estate investment trust that owns and leases outpatient medical facilities and specialty properties in secondary markets. The company benefits from stable demographic demand and a specialized focus on non-urban healthcare assets that face lighter institutional competition. However, its growth is constrained by a smaller market capitalization, elevated payout ratios, and sensitivity to rising interest rates and financing costs. It represents a high-yield option best suited for income-focused investors willing to accept higher financial and concentration risks. Investors should closely monitor portfolio occupancy, debt maturities, and dividend coverage sustainability.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitCHCT is a slow-growth REIT focused on income generation rather than rapid capital appreciation.
Momentum investorWeak fitStrong fit while signal remains positive; momentum metrics are typically subdued due to defensive small-cap REIT trading patterns.
Value investorMixed fitTrading at lower valuation multiples relative to peers, but warrants caution regarding leverage and payout risks.
Dividend investorStrong fitThe stock offers an exceptionally high dividend yield, though investors must monitor payout sustainability.
Low-risk investorWeak fitSmaller market capitalization and high payout ratios introduce meaningful volatility and credit risks.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highSmall-cap REIT status exposes the stock to broader market swings and interest rate sentiment.
Valuation riskMediumAlthough trading at lower multiples, asset values are sensitive to cap rate expansions.
Competition risk (healthcare real estate market competition)MediumCompetition for quality healthcare properties can compress acquisition yields.
Business qualityMediumA specialized portfolio in non-urban markets brings variable tenant credit profiles.
Dividend incomeHighHigh payout ratios mean dividend coverage requires close monitoring against earnings pressure.
Execution riskMediumReliance on external capital markets to fund ongoing property acquisitions introduces execution hurdles.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 422.76M USD
Price to earnings Ratio 20.15
1Y Target Price 17
Price to earnings Ratio 20.15
1Y Target Price 17
Volume (30-day avg) 363.5K shares
Beta 0.63
52 Weeks Range 12.30 - 18.32
Updated Date 11/15/2026
52 Weeks Range 12.30 - 18.32
Updated Date 11/15/2026
Dividends yield (FY) 11.24%
Basic EPS (TTM) 0.73

Sector & Industry Intelligence

Sector

Real Estate

Constructive
Sentiment
Strong Bullish
Momentum
BUY Breadth Improving
BUY participation
64.5%
Active BUY / eligible
20 / 31
30-Day BUY Count Change
+16
Market state
Strong Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

REIT - Healthcare Facilities

BUY participation
100.0%
Active BUY / eligible
4 / 4
30-Day BUY Count Change
+4

Eligible universe: 4 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit -22.17%
Avg. Invested days 45
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
CHCT receives a 3-star rating, supported by solid company fundamentals. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
CHCT has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and strong ownership. In FY2025 versus FY2024, strong earnings growth (+260.4%) and strong cash generation (FCF margin 29.6%) are partially offset by moderate revenue growth (+4.7%), soft profitability (net margin 4.2%).

Financial Health Rating

★★★★★
CHCT's financial health is supported by solid cash strength, including free-cash-flow generation (29.6% of revenue). Liquidity is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is CHCT's strongest growth driver at +260.4% FY2025 versus FY2024 (strong, 5 stars). By comparison, while revenue growth (+4.7%, moderate) and free-cash-flow growth (+4.9%, moderate) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 83.2% and approximately 87.9% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 6.46% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 9.18%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 7.16%
Vanguard Portfolio Management, LLC 5.07%
Systematic Financial Management LP 4.12%
Vanguard Capital Management, LLC 4.11%

Unit Economics (Per $1K Revenue)

★★★★★
CHCT generates approximately $87 of gross profit, $167 of operating income, and $296 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Moderate margins and strong cash conversion support a 3-star rating, while capital efficiency is weak.

Economic Dimensions

★★★★★
Effective Tax Rate: 0.45%

Quantitative Style Profile

★★★★★
CHCT has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Outpatient Medical Real Estate LeasingRental income generated from triple-net leases on medical office buildings, clinics, and specialty centers.The company acts as a landlord collecting predictable rental payments from healthcare operators.
Mortgage and Financing InterestInterest income derived from mortgage loans provided to healthcare operators and facility developers.Earns interest revenue by financing real estate projects for medical service providers.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-03
When After Market
Estimate 0.47
Actual 0.58

Profitability

Profit Margin 17.76%
Operating Margin (TTM) 28.14%

Management Effectiveness

Return on Assets (TTM) 2.23%
Return on Equity (TTM) 5.33%

Valuation

Trailing PE 20.15
Forward PE 37.31
Enterprise Value 983.76M
Price to Sales(TTM) 3.35
Enterprise Value 983.76M
Price to Sales(TTM) 3.35
Enterprise Value to Revenue 7.8
Enterprise Value to EBITDA 10.32
Shares Outstanding 28.74M
Shares Floating 25.26M
Shares Outstanding 28.74M
Shares Floating 25.26M
Percent Insiders 6.46
Percent Institutions 83.15

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.